English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Athimalaipet Ramanan, Kamal N. Bharucha, Hermine I. Brunner, Nicola Ruperto, David A. Cabral, Abraham Gedalia, Valeria Gerloni, Christian Jorgensen, Daniel J. Lovell, Alberto Martini, Jim Frane, Chris Wells and Fabrizio De Benedetti Paediatric Rheumatology, Bristol Royal Hospital for Children, Bristol, Royal National Hospital for Rheumatic Diseases, Bath, UK, Medical Department, Genentech, South San Francisco, CA, Pediatric Rheumatology Collaborative Study Group, PRCSG, Cincinnati, OH, USA, Paediatric Rheumatology International Trials Organisation, Genoa, Italy, Consultant, Rheumatology Department, Santa Monica, CA, USA, Medical Department, Roche Products Ltd, Welwyn Garden City, UK and Department of Pediatric Medicine, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy

rheumatology

277. Growth During Tocilizumab Therapy in Patients with Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data from the Phase III Cherish Trial